FDA Inspection 1164113 — Huvepharma Inc
The FDA completed an inspection of Huvepharma Inc on Mar 9, 2022 in Peachtree City, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 9, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Bioresearch Monitoring
- Location
- Peachtree City, GA (United States)
Additional Details
Sponsor, Contract Research Organization